
Samsung Biologics to Acquire PolyPeptide in All-Cash Deal, Expanding Global Manufacturing
PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.

PolyPeptide's specialized peptide expertise and global multi-site network to strengthen Samsung Biologics' multi-modality and global manufacturing excellence.

DCAT reports that FDA has selected seven companies for its new PreCheck Pilot Program, designed to encourage US-based drug manufacturing through earlier engagement and a more predictable regulatory path.

As Managing Director, Lisa will provide strategic leadership for BASF in the UK, supporting the company’s licence to operate and ensuring the business continues to contribute to BASF’s long-term success.

Ovomas, a start-up from Ecuador, creates high-value pharmaceutical products from eggshell waste, including high-purity calcium citrate, nutraceutical capsules, and vitamin-enriched gummies.

Air Liquide is investing over $160 million to build a new Arizona facility supplying ultra-high-purity gases, including low-carbon hydrogen, to a leading chipmaker's fab expansion, starting operations in 2028.

Olon has completed a major expansion at its Concord, Ohio facility, doubling production capacity and strengthening the site's role as a US manufacturing hub within its global development network.

Shell has agreed to sell its Sprng Energy renewables business in India to Aditya Birla Renewables for $1.8 billion, as part of its strategy to streamline and improve returns in its power portfolio.

Fujifilm Biotechnologies' Holly Springs, NC facility has been chosen as one of seven participants in the FDA's PreCheck Pilot Program, aimed at strengthening US pharmaceutical manufacturing and regulatory readiness.

Syensqo has broken ground on a multi-million-dollar expansion at its Havre de Grace, MD site, boosting capacity by over 30% to meet growing aerospace demand for structural adhesives and surfacing products.

Innexis plans to acquire the multi-user facility in Kundl, Tyrol, from Novartis.

Ineos and Recuro have signed a Memorandum of Understanding to develop a state-of-the-art advanced recycling facility at Ineos’ Bamble polymer site in Norway.

Evonik is modernizing the API production at its Tippecanoe site in the US Over the next five years, the company will invest $100 million in upgrading key plant components.

New capabilities help product development teams move from product goals to suggested experiments in minutes, with stronger predictive models behind the workflow.

Syngene International announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026.

Berlin start-up company Ucaneo brings industrial-scale carbon removal online just 18 months after groundbreaking.

Exære wins the From Lab to Market Challenge 2026 with technology to recover rare earth elements from e-waste. ESILIB and CarboNano.EU also placed; ReduCO2 took the CHEManager special award.

Russell Thomas, who has held senior roles at both organisations, takes on the joint CSO position as Symeres and Axxam push to offer clients a single pipeline spanning target screening to IND-ready drug candidates.

The goal is to tailor the business optimally to the specific requirements of the US market. Ruveon will focus on all aspects of the US glyphosate business.

Rentschler Biopharma has appointed Torsten Woehr as Chief Executive Officer (CEO), effective August 1, 2026.

The Coatings transaction between Carlyle and BASF, announced on October 10, 2025, was completed on June 30, 2026.

CDMO Adragos Pharma Kawagoe and Towa Pharmaceutical have agreed to a manufacturing partnership that will nearly triple solid-dosage capacity, shoring up Japan's fragile generics supply chain.

Bucci Composites gains access to Syensqo's Double Diaphragm Forming process as both firms aim to qualify materials with OEMs and lift production of structural parts and battery housings.

Ineos Enterprises has completed the sale of Ineos Calabrian, its ultra-pure sulfur dioxide and derivatives business, to Ecovyst.

Lonza to expand payload-linker manufacturing capacity in Visp (CH) to support the rapidly growing antibody-drug conjugate (ADC) market.

Covestro is supporting its growth ambitions in the MDI market by building an MDI production facility at its Shanghai site.

Bayer and Iambic Therapeutics are collaborating to research new drugs using Iambic's AI-based platform. The collaboration focuses on the discovery of small molecules.

Indian start-up Environalgae develops and implements microalgae-based wastewater treatment plants tailored to the specific waste streams of each customer.

IMCD is acquiring Merit Solution, a Thai distributor of plastic additives, to strengthen its position in the plastics and compounding market in Thailand and Southeast Asia.

Merck has agreed to acquire Bio-Techne in an all-cash deal valuing the company at approximately $11.3 billion.

The U.S. Supreme Court has issued a landmark ruling on glyphosate, the active ingredient in Roundup.

IMCD has opened a new Pharmaceutical Technical Centre and Food & Nutrition Hub in Allendale, NJ — bringing labs, co-creation space, and global expertise together to speed up product development.

Lars Wallstein will join the management team of the German chemical distributor Oqema effective July 1, 2026.

Dow is pumping $100M into silicones manufacturing across the US, China, and Japan — accelerating supply for EVs, electronics, and medical devices.

AI in pharma has moved past the hype cycle and into implementation. The organizations that pull ahead won't have the most sophisticated models — they'll have the strongest evidence foundation underneath them.
